Metformin is a commonly used treatment for patients with diabetes but may infrequently cause lactic acidosis, a condition associated with a very high mortality. The most effective treatment of this condition is intermittent haemodialysis, but many patients cannot tolerate the significant hypotension that the therapy causes. Other renal replacement modalities that cause less hypotension and use convective solute clearance do not appear as effective. The use of continuous renal replacement therapy that employs a dialysis component has not been reported.
We report the successful treatment of a patient with metformin-induced lactic acidosis with highdose continuous haemodiafiltration
CASE HISTORY
A 74-year-old man was admitted to our cardiothoracic intensive care unit (CTICU) with severe lactic acidosis. He had a background history of hypertension, hyperlipidaemia and had recently undergone coronary artery bypass graft surgery and mechanical mitral valve replacement. His postoperative course had been complicated by congestive heart failure and pleural effusions requiring repeated hospital admissions.
Five days prior to admission to CTICU, the patient had been readmitted to hospital with severe dyspnoea attributable to congestive heart failure, worsening renal impairment (serum creatinine 241 µmol/l) and anaemia. A transthoracic echocardiograph demonstrated an ejection fraction of 35% with normal function of the mitral valve prosthesis. His haemoglobin on admission was noted to be 6.7 g/dl. The patient was transfused with packed red blood cells and was investigated for possible causes of anaemia. He was also treated with increasing doses of loop diuretics and fluid restriction.
Three days after admission, the patient developed haematemesis with associated hypotension. He underwent an urgent oesophagogastroduodenoscopy and was found to have gastritis but no other obvious source of bleeding. However, the patient developed progressive hypotension (blood pressure 86/40) despite transfusion and was admitted to the CTICU for further management.
On admission to the CTICU, the patient was noted to be lethargic and tachypnoeic with laboured breathing. The first arterial blood gas analysis showed a severe metabolic acidosis with pH 6.88, P a CO 2 28.7 mmHg, P a O 2 93.2 mmHg and base excess of -26.7 mmol/l. The serum lactate level was higher than the upper reference limit of the laboratory (>15.5 mmol/l). The patient was sedated, the trachea intubated and mechanical ventilatory support was commenced (assist control mode, rate 18 breaths per minute, tidal volume of 500 ml and positive end-expiratory pressure of 5 cmH 2 O). A central line was inserted and dobutamine (15 µg/kg/minute), noradrenaline (0.12 µg/kg/minute) and 8.4% sodium bicarbonate infusions (100 ml/hour) were commenced. It was noted at that time that the patient had been continued on metformin 850 mg three times per day despite his renal impairment. A presumptive diagnosis of metformin-induced lactic acidosis was made. The metformin was ceased.
Continuous veno-venous haemodiafiltration (CVVHDF) was started through an intravenous catheter (Mahukar Tyco Healthcare group, Mansfield, MA, USA) inserted in the right femoral vein. Haemodiafiltration was performed (Prisma, Gambro, Medolla, Italy) using a bicarbonatebuffered replacement fluid (Hemosol, Gambro, Italy) with a blood flow rate set at 180 ml/minute, dialysis rate at 40 ml/kg/hour and an ultrafiltration rate of 40 ml/kg/hour. Anticoagulation was achieved using acid citrate dextrose. Six hours after initiation of haemodiafiltration, there was steady improvement in his acidbase balance.
Twenty-four hours after initiating CVVHDF, the patient's lactate level was 2.3 mmol/l. After 72 hours CVVHDF and the inotropes were ceased. During the course of his recovery, he developed episodic atrial fibrillation which was treated successfully with amiodarone. His stay was further complicated by severe aspiration pneumonia which was treated with intravenous meropenem. He required ventilatory support for 20 days and was weaned with the support of a percutaneous tracheostomy.
After 28 days in CTICU, the tracheostomy tube was removed and the patient was discharged to the general ward. He did not require further CVVHDF and his serum creatinine returned to a baseline level of 163 µmol/l. After a further 14 days on the ward, he was discharged from the hospital in a stable condition.
DISCUSSION
Metformin is a biguanide antiglycaemic agent which lowers blood glucose by decreasing gastrointestinal absorption, decreasing gluconeogenesis and increasing peripheral utilisation of glucose 1 . The use of metformin has been associated with severe lactic acidosis which, while uncommon, has a mortality of approximately 50% 2 . Although the exact mechanism for causing lactic acidosis is not understood, it is postulated that biguanides induce it by inhibiting certain microsomal enzymes involved in glucose metabolism 3 . Metformin is excreted largely unchanged in the urine by the kidneys. Accumulation of metformin and precipitation of lactic acidosis is known to be more common in patients with renal impairment 3 . Other risk factors for the development of metformin-induced lactic acidosis include renal impairment, cardiac failure, liver disease, haemodynamic instability and metformin overdose 4 . There have been few recent reports in the literature on metformin-induced lactic acidosis in the intensive care environment. Treatment of the condition may be difficult, especially in haemodynamically unstable patients. Options include intravenous sodium bicarbonate, intermittent haemodialysis and continuous venovenous haemofiltration. Sodium bicarbonate alone usually fails to correct the acidosis, may cause intracellular acidosis and hypernatraemia, and does not remove metformin 2 . Better outcomes have been seen with continuous venovenous haemofiltration (CVVHF) or haemodialysis 4 . This is thought to simultaneously correct the metabolic acidosis and remove metformin from the patient, with a reported clearance of up to 170 ml/minute by dialysis 5 . CCVHF is well tolerated in patients with haemodynamic compromise and is frequently used in critically ill patients 6 . However, CVVHF appears to be less effective than haemodialysis and may be inadequate when used in isolation. For example, in one report of metformin overdose, CVVHF alone was ineffective. Highflux haemofiltration via a second line was needed, with eventual resolution of the patient's acidosis 3 . To the best of our knowledge, there has been no published experience with CVVHDF for metformininduced lactic acidosis. While the treatment of . Given the apparently limited success of CVVHF and the haemodynamic instability of our patient, we chose CVVHDF, using a substantially higher continuous renal replacement therapy dose than is generally recommended 6 . Although metformin levels were not quantified, our strategy appeared effective.
Clinicians using metformin should remain cognisant that the drug is contraindicated in patients with renal impairment and cardiac failure. In those with metformin-induced lactic acidosis, CVVHDF appears effective.
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